Let's us Introduce

At Freeway, we are devoted to revolutionizing interventional care through relentless innovation in medical devices, specifically focusing on percutaneous  coronary interventions. Our vision is to be the global leader recognized for  groundbreaking advancements in coronary intervention and next-generation  complex PCI therapies.

We strive to set new standards in patient care, delivering exceptional, life-enhancing medical technologies. Driven by our core values of trust, modernity, and professionalism, with an added touch of luxury  and youthful energy. 

we aim to serve humanity by designing and manufacturing  the best-in-class coronary dilatation catheters. Our commitment to bold innovation and excellent R&D enables us to launch successful product lines,  including our forthcoming entry into the US market, while standing out from the competition and inspiring trust among healthcare providers worldwide. 

WE ARE YOUNG , WE ARE PASSION , WE ARE CURIOUS , WE ARE FREEWAY ! 

We want to go above and beyond !


Meet Our CEO
"rethinking the possibilities"

-Kiran Pattnaik (CEO and Founder of Freeway)

2023
  • Freeway incorporated in Fujian Province china its R&D and manufacturing facility Factory with fully equipped Class 7 cleanroom
2024
  • Freeway Received ISO13485 Certification
  • Design Validation Closure for catheter based cardiovascular devices
  • launch for Cutting Balloon & Drug Coated Balloon (Coronary & Peripheral)
  • Launch of CTO balloons 0.75-1.0mm
2025
  • Freeway Moving towards FDA51OKvalidations
  • IVL Development completed(Coronary)
2023
2024
2025